20.10.2022 12:00:00

Dow reports third quarter 2022 results

MIDLAND, Mich., Oct. 20, 2022 /PRNewswire/ -- Dow (NYSE: DOW):

www.dow.com (PRNewsfoto/The Dow Chemical Company)

FINANCIAL HIGHLIGHTS
  • GAAP earnings per share (EPS) was $1.02; Operating EPS1 was $1.11, compared to $2.75 in the year-ago period and $2.31 in the prior quarter, reflecting margin compression due to higher energy costs, primarily in Europe, the Middle East, Africa and India (EMEAI).
  • Net sales were $14.1 billion, down 5% versus the year-ago period, as gains in Performance Materials & Coatings were more than offset by declines in Industrial Intermediates & Infrastructure and Packaging & Specialty Plastics. Sequentially, sales were down 10% with declines in all operating segments and regions.
  • Local price increased 3% versus the year-ago period, driven by Performance Materials & Coatings and Industrial Intermediates & Infrastructure. Sequentially, local price decreased 6% with declines in all operating segments and regions.
  • Currency decreased net sales by 4% year-over-year and 1% versus the prior quarter due to broad-based strength of the U.S. dollar.
  • Volume was down 4% versus the year-ago period, as a 12% decline in EMEAI more than offset 2% volume growth each in the U.S. & Canada and Asia Pacific. Sequentially, volume was down 3%, led by an 8% decline in EMEAI.
  • Equity losses were $58 million, compared to equity earnings of $249 million in the year-ago period and $195 million in the prior quarter, led by margin compression in polyurethanes at Sadara and MEG at the Kuwait joint ventures.
  • GAAP Net Income was $760 million. Operating EBIT1 was $1.2 billion, down from $2.9 billion in the year-ago period, as gains in Performance Materials & Coatings were more than offset by higher raw material and energy costs as well as lower equity earnings. Operating EBIT decreased from $2.4 billion in the prior quarter due to margin compression across all operating segments.
  • Cash provided by operating activities – continuing operations was $1.9 billion, down $779 million year-over-year and up $84 million compared to the prior quarter. Free cash flow1 was $1.5 billion.
  • Returns to shareholders totaled $1.3 billion, comprised of $800 million in share repurchases and $493 million in dividends in the quarter.
SUMMARY FINANCIAL RESULTS

Three Months Ended September 30

Three Months Ended June 30

In millions, except per share amounts

3Q22

3Q21

vs. SQLY

[B / (W)]

2Q22

vs. PQ

[B / (W)]

Net Sales

$14,115

$14,837

$(722)

$15,664

$(1,549)

GAAP Income, Net of Tax

$760

$1,706

$(946)

$1,681

$(921)

Operating EBIT¹

$1,195

$2,886

$(1,691)

$2,375

$(1,180)

Operating EBIT Margin¹

8.5 %

19.5 %

(1,100) bps  

15.2 %

(670) bps  

Operating EBITDA¹

$1,863

$3,611

$(1,748)

$3,059

$(1,196)

GAAP Earnings Per Share

$1.02

$2.23

$(1.21)

$2.26

$(1.24)

Operating Earnings Per Share¹

$1.11

$2.75

$(1.64)

$2.31

$(1.20)

Cash Provided by Operating
Activities – Cont. Ops

$1,940

$2,719

$(779)

$1,856

$84

  • Op. Earnings Per Share, Op. EBIT, Op. EBIT Margin, Op. EBITDA, and Free Cash Flow are non-GAAP measures. See page 6 for further discussion.
  • CEO QUOTE

    Jim Fitterling, chairman and chief executive officer, commented on the quarter:

    "In the third quarter, Team Dow managed significant macroeconomic headwinds as we swiftly initiated actions and aligned production with supply chain and logistics constraints, prioritized resources toward higher-value products, and reduced operational costs across the enterprise. As a result, we maintained our focus on cash flow generation and continued to execute on our capital allocation strategy, returning $1.3 billion to shareholders.

    "Underlying demand remains resilient in the U.S., while high energy and feedstock costs are driving record inflation and impacting demand in the Eurozone, and ongoing lockdowns in China continue to pressure both consumer spending and infrastructure investments. Moving forward, our global scale, geographic diversity, and advantaged feedstock and derivative flexibility will continue to be the source of our distinct advantages. Our track record of employing a disciplined and balanced approach to capital allocation, focus on cash flow generation, and our strengthened balance sheet provide a solid foundation as we continue managing through these dynamic global conditions."

    SEGMENT HIGHLIGHTS

    Packaging & Specialty Plastics


    Three Months Ended September 30

    Three Months Ended June 30

    In millions, except margin
    percentages

    3Q22

    3Q21

    vs. SQLY

    [B / (W)]

    2Q22

    vs. PQ

    [B / (W)]

    Net Sales

    $7,327

    $7,736

    $(409)

    $8,233

    $(906)

    Operating EBIT

    $785

    $1,954

    $(1,169)

    $1,436

    $(651)

    Operating EBIT Margin

    10.7 %

    25.3 %

    (1,460) bps  

    17.4 %

    (670) bps  

    Equity Earnings

    $55

    $124

    $(69)

    $138

    $(83)

    Packaging & Specialty Plastics segment net sales in the quarter were $7.3 billion, down 5% versus the year-ago period. Local price decreased 2% year-over-year, as gains in functional polymers were more than offset by lower polyethylene prices. Volume was flat year-over-year and currency decreased net sales by 3%. On a sequential basis, net sales decreased by 11%, primarily driven by lower polyethylene prices and reduced volumes due to continued global logistics constraints and dynamic market conditions in EMEAI.

    Equity earnings were $55 million, down $69 million compared to the year-ago period and down $83 million versus the prior quarter, primarily due to lower integrated polyethylene margins at the Company's principal joint ventures.

    Operating EBIT was $785 million, compared to $2 billion in the year-ago period, down primarily due to higher raw material and energy costs. Sequentially, Op. EBIT was down $651 million and Op. EBIT margins decreased by 670 basis points primarily due to lower local prices.

    Packaging and Specialty Plastics business reported a net sales decrease versus the year-ago period as price gains and resilient demand in functional polymers were more than offset by lower polyethylene prices and reduced demand for industrial and consumer packaging in EMEAI. Sequentially, net sales decreased on lower polyethylene prices and reduced volumes due to continued global logistics constraints and dynamic market conditions in EMEAI.

    Hydrocarbons & Energy business reported a net sales increase compared to the year-ago period, driven primarily by higher electricity sales and partly offset by currency impacts. Sequentially, net sales decreased due to lower olefin prices in EMEAI and the U.S. & Canada.

    Industrial Intermediates & Infrastructure


    Three Months Ended September 30

    Three Months Ended June 30

    In millions, except margin
    percentages

    3Q22

    3Q21

    vs. SQLY

    [B / (W)]

    2Q22

    vs. PQ

    [B / (W)]

    Net Sales

    $4,059

    $4,481

    $(422)

    $4,370

    $(311)

    Operating EBIT

    $167

    $713

    $(546)

    $426

    $(259)

    Operating EBIT Margin

    4.1 %

    15.9 %

    (1,180) bps  

    9.7 %

    (560) bps  

    Equity Earnings (Losses)

    $(114)

    $122

    $(236)

    $57

    $(171)

    Industrial Intermediates & Infrastructure segment net sales were $4.1 billion, down 9% versus the year-ago period. Local price improved 5% year-over-year with gains in both businesses. Currency decreased net sales by 5%. Volume was down 9% year-over-year, as declines in Polyurethanes & Construction Chemicals were partly offset by gains in Industrial Solutions due to demand strength in pharmaceutical, agricultural, and energy applications. On a sequential basis, the segment recorded a net sales decline of 7% on lower local price and currency with stable volume.  

    Equity losses for the segment were $114 million, a decrease of $236 million compared to the year-ago period. Competitive pricing pressures in propylene oxide derivatives and MEG due to supply additions in China, as well as lower demand in EMEAI were the main impacts. On a sequential basis, equity earnings decreased by $171 million primarily due to lower price at Sadara and the Kuwait joint ventures.

    Operating EBIT was $167 million, compared to $713 million in the year-ago period and $426 million in the prior quarter, as lower EMEAI demand and increased energy and raw material costs were partly offset by higher prices. On a sequential basis, operating EBIT margins declined 560 basis points on lower price and higher energy costs.

    Polyurethanes & Construction Chemicals business reported a net sales decrease compared to the year-ago period, as local price gains were more than offset by lower volumes due to inflationary pressures on demand in EMEAI and currency impacts. Sequentially, net sales declined as improved demand in mobility end-markets was more than offset by lower price and inflationary impacts on demand for consumer durables, industrial, and building & construction applications.

    Industrial Solutions business reported a net sales increase compared to the year-ago period, driven by local price gains and strong demand for pharmaceutical, agricultural, and energy applications. Sequentially, net sales decreased as strong demand in energy, pharmaceutical, and mobility end-markets and increased catalyst sales were more than offset by price declines and currency impacts.

    Performance Materials & Coatings


    Three Months Ended September 30

    Three Months Ended June 30

    In millions, except margin
    percentages

    3Q22

    3Q21

    vs. SQLY

    [B / (W)]

    2Q22

    vs. PQ

    [B / (W)]

    Net Sales

    $2,654

    $2,526

    $128

    $3,003

    $(349)

    Operating EBIT

    $302

    $284

    $18

    $561

    $(259)

    Operating EBIT Margin

    11.4 %

    11.2 %

    20 bps  

    18.7 %

    (730) bps  

    Equity Earnings

    $1

    $3

    $(2)

    $2

    $(1)

    Performance Materials & Coatings segment net sales in the quarter were $2.7 billion, up 5% versus the year-ago period. Local price increased 15% year-over-year, with gains in both businesses and all regions. Currency decreased net sales by 5%. Volume declined 5% year-over-year, as resilient demand in mobility and home care end-markets was more than offset by declines in building & construction. On a sequential basis, net sales were down 12% driven primarily by lower demand and decreased local price for siloxanes due to supply additions in China along with planned maintenance turnaround activity.

    Operating EBIT was $302 million, compared to $284 million in the year-ago period, as Op. EBIT margins expanded by 20 basis points due to price gains for both silicones and coatings applications. Sequentially, Op. EBIT declined $259 million driven by lower prices for siloxanes and increased raw material and energy costs.

    Consumer Solutions business reported higher net sales versus the year-ago period, with local price gains across all regions and end-markets. Volume declined year-over-year as lower siloxane demand and planned maintenance turnaround activity was partly offset by resilient demand for performance silicones applications. Sequentially, net sales declined due to lower siloxane demand and pricing as well as planned maintenance turnaround activity, which more than offset demand strength for performance silicones in electronics, home care and mobility end-markets.

    Coatings & Performance Monomers business reported lower net sales compared to the year-ago period, as local price gains were more than offset by lower demand primarily in EMEAI and Asia Pacific. Sequentially, net sales declined as increased demand for monomers was more than offset by lower demand for coatings applications in the U.S. & Canada and EMEAI.

    OUTLOOK

    "In the near-term, we expect the macro environment to remain dynamic. As a result, we have outlined a playbook of actions that have the potential to deliver more than $1 billion in cost savings in 2023 while we continue to leverage our scale, geographic diversity and feedstock and derivative flexibility," said Fitterling. "At the same time, we remain focused on advancing our Decarbonize and Grow strategy with higher-return investments that will extend our competitive advantages and industry leadership positions. Our strong financial position and balance sheet as well as our continued focus on cash flow generation give us ample flexibility to execute on our capital allocation priorities, including attractive shareholder remuneration, as we maximize value creation over the longer-term."

    Conference Call

    Dow will host a live webcast of its third quarter earnings conference call with investors to discuss its results, business outlook and other matters today at 8:00 a.m. ET. The webcast and slide presentation that accompany the conference call will be posted on the events and presentations page of investors.dow.com.

    About Dow

    Dow (NYSE: DOW) combines global breadth; asset integration and scale; focused innovation and materials science expertise; leading business positions; and environmental, social and governance (ESG) leadership to achieve profitable growth and deliver a sustainable future. The Company's ambition is to become the most innovative, customer centric, inclusive and sustainable materials science company in the world. Dow's portfolio of plastics, industrial intermediates, coatings and silicones businesses delivers a broad range of differentiated, science-based products and solutions for its customers in high-growth market segments, such as packaging, infrastructure, mobility and consumer applications. Dow operates 104 manufacturing sites in 31 countries and employs approximately 35,700 people. Dow delivered sales of approximately $55 billion in 2021. References to Dow or the Company mean Dow Inc. and its subsidiaries. For more information, please visit www.dow.com or follow @DowNewsroom on Twitter.

    Cautionary Statement about Forward-Looking Statements

    Certain statements in this report are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would" and similar expressions, and variations or negatives of these words or phrases.

    Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow's control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow's products; Dow's expenses, future revenues and profitability; the continuing global and regional economic impacts of the coronavirus disease 2019 ("COVID-19") pandemic and other public health-related risks and events on Dow's business; any sanction, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflict between Russia and Ukraine; capital requirements and need for and availability of financing; unexpected barriers in the development of technology, including with respect to Dow's contemplated capital and operating projects; Dow's ability to realize its commitment to carbon neutrality on the contemplated timeframe; size of the markets for Dow's products and services and ability to compete in such markets; failure to develop and market new products and optimally manage product life cycles; the rate and degree of market acceptance of Dow's products; significant litigation and environmental matters and related contingencies and unexpected expenses; the success of competing technologies that are or may become available; the ability to protect Dow's intellectual property in the United States and abroad; developments related to contemplated restructuring activities and proposed divestitures or acquisitions such as workforce reduction, manufacturing facility and/or asset closure and related exit and disposal activities, and the benefits and costs associated with each of the foregoing; fluctuations in energy and raw material prices; management of process safety and product stewardship; changes in relationships with Dow's significant customers and suppliers; changes in consumer preferences and demand; changes in laws and regulations, political conditions or industry development; global economic and capital markets conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war including the ongoing conflict between Russia and Ukraine; weather events and natural disasters; disruptions in Dow's information technology networks and systems; and risks related to Dow's separation from DowDuPont Inc. such as Dow's obligation to indemnify DuPont de Nemours, Inc. and/or Corteva, Inc. for certain liabilities.

    Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2021 and the Company's subsequent Quarterly Reports on Form 10-Q. These are not the only risks and uncertainties that Dow faces. There may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not currently expect to have a material impact on its business. If any of those risks or uncertainties develops into an actual event, it could have a material adverse effect on Dow's business. Dow and TDCC assume no obligation to update or revise publicly any forward-looking statements whether because of new information, future events, or otherwise, except as required by securities and other applicable laws. 

    Non-GAAP Financial Measures

    This earnings release includes information that does not conform to U.S. GAAP and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company's segments, including allocating resources. Dow's management believes that these non-GAAP measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year-over-year results. These non-GAAP measures supplement the Company's U.S. GAAP disclosures and should not be viewed as alternatives to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Non-GAAP measures included in this release are defined below. Reconciliations for these non-GAAP measures to U.S. GAAP are provided in the Selected Financial Information and Non-GAAP Measures section starting on page 11. Dow does not provide forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.

    Operating Earnings Per Share is defined as "Earnings per common share - diluted" excluding the after-tax impact of significant items.

    Operating EBIT is defined as earnings (i.e., "Income before income taxes") before interest, excluding the impact of significant items.

    Operating EBIT Margin is defined as Operating EBIT as a percentage of net sales.

    Operating EBITDA is defined as earnings (i.e., "Income before income taxes") before interest, depreciation and amortization, excluding the impact of significant items.

    Free Cash Flow is defined as "Cash provided by operating activities - continuing operations," less capital expenditures. Under this definition, Free Cash Flow represents the cash generated by the Company from operations after investing in its asset base. Free Cash Flow, combined with cash balances and other sources of liquidity, represent the cash available to fund obligations and provide returns to shareholders. Free Cash Flow is an integral financial measure used in the Company's financial planning process.

    Cash Flow Conversion is defined as "Cash provided by operating activities - continuing operations," divided by Operating EBITDA. Management believes Cash Flow Conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings into cash flow.

    Operating Return on Capital (ROC) is defined as net operating profit after tax, excluding the impact of significant items, divided by total average capital, also referred to as ROIC.

     

    Dow Inc. and Subsidiaries

    Consolidated Statements of Income


    In millions, except per share amounts (Unaudited)

    Three Months Ended

    Nine Months Ended

    Sep 30,
    2022

    Sep 30,
    2021

    Sep 30,
    2022

    Sep 30,
    2021

    Net sales

    $   14,115

    $   14,837

    $   45,043

    $   40,604

    Cost of sales

    12,381

    11,611

    37,682

    32,413

    Research and development expenses

    191

    210

    626

    632

    Selling, general and administrative expenses

    356

    403

    1,289

    1,209

    Amortization of intangibles

    83

    100

    256

    301

    Restructuring and asset related charges - net

    186

    22

    Equity in earnings (losses) of nonconsolidated affiliates

    (58)

    249

    311

    751

    Sundry income (expense) - net

    69

    (350)

    292

    (225)

    Interest income

    41

    14

    105

    35

    Interest expense and amortization of debt discount

    155

    178

    487

    561

    Income before income taxes

    1,001

    2,248

    5,225

    6,027

    Provision for income taxes

    241

    542

    1,232

    1,383

    Net income

    760

    1,706

    3,993

    4,644

    Net income attributable to noncontrolling interests

    21

    23

    24

    69

    Net income available for Dow Inc. common stockholders

    $       739

    $     1,683

    $     3,969

    $     4,575






    Per common share data:





    Earnings per common share - basic

    $      1.03

    $      2.25

    $      5.45

    $      6.11

    Earnings per common share - diluted

    $      1.02

    $      2.23

    $      5.41

    $      6.06






    Weighted-average common shares outstanding - basic

    714.3

    744.5

    724.9

    745.4

    Weighted-average common shares outstanding - diluted

    718.1

    750.0

    729.8

    750.9

     

    Dow Inc. and Subsidiaries

    Consolidated Balance Sheets


    In millions, except share amounts (Unaudited)

    Sep 30,
    2022

    Dec 31,
    2021

    Assets



    Current Assets



    Cash and cash equivalents

    $         2,216

    $         2,988

    Accounts and notes receivable:



    Trade (net of allowance for doubtful receivables - 2022: $212; 2021: $54)

    6,407

    6,841

    Other

    2,123

    2,713

    Inventories

    7,571

    7,372

    Other current assets

    1,460

    934

    Total current assets

    19,777

    20,848

    Investments



    Investment in nonconsolidated affiliates

    1,785

    2,045

    Other investments (investments carried at fair value - 2022: $1,685; 2021: $2,079)

    2,732

    3,193

    Noncurrent receivables

    499

    478

    Total investments

    5,016

    5,716

    Property



    Property

    56,931

    57,604

    Less: Accumulated depreciation

    36,899

    37,049

    Net property

    20,032

    20,555

    Other Assets



    Goodwill

    8,524

    8,764

    Other intangible assets (net of accumulated amortization - 2022: $4,888; 2021: $4,725)

    2,483

    2,881

    Operating lease right-of-use assets

    1,231

    1,412

    Deferred income tax assets

    1,136

    1,358

    Deferred charges and other assets

    1,358

    1,456

    Total other assets

    14,732

    15,871

    Total Assets

    $       59,557

    $       62,990

    Liabilities and Equity



    Current Liabilities



    Notes payable

    $            185

    $            161

    Long-term debt due within one year

    364

    231

    Accounts payable:



    Trade

    5,008

    5,577

    Other

    2,599

    2,839

    Operating lease liabilities - current

    277

    314

    Income taxes payable

    579

    623

    Accrued and other current liabilities

    3,303

    3,481

    Total current liabilities

    12,315

    13,226

    Long-Term Debt

    12,921

    14,280

    Other Noncurrent Liabilities



    Deferred income tax liabilities

    716

    506

    Pension and other postretirement benefits - noncurrent

    6,541

    7,557

    Asbestos-related liabilities - noncurrent

    868

    931

    Operating lease liabilities - noncurrent

    1,012

    1,149

    Other noncurrent obligations

    6,555

    6,602

    Total other noncurrent liabilities

    15,692

    16,745

    Stockholders' Equity



    Common stock (authorized 5,000,000,000 shares of $0.01 par value each;

    issued 2022: 768,611,564 shares; 2021: 764,226,882 shares)

    8

    8

    Additional paid-in capital

    8,396

    8,151

    Retained earnings

    23,068

    20,623

    Accumulated other comprehensive loss

    (9,582)

    (8,977)

    Unearned ESOP shares

    (15)

    Treasury stock at cost (2022: 64,852,295 shares; 2021: 29,011,573 shares)

    (3,773)

    (1,625)

    Dow Inc.'s stockholders' equity

    18,117

    18,165

    Noncontrolling interests

    512

    574

    Total equity

    18,629

    18,739

    Total Liabilities and Equity

    $       59,557

    $       62,990

     

    Dow Inc. and Subsidiaries

    Consolidated Statements of Cash Flows


    In millions (Unaudited)

    Nine Months Ended

    Sep 30,
    2022

    Sep 30,
    2021

    Operating Activities



    Net income

    $       3,993

    $       4,644

    Adjustments to reconcile net income to net cash provided by operating activities:



    Depreciation and amortization

    2,104

    2,187

    Provision for deferred income tax

    124

    488

    Earnings of nonconsolidated affiliates less than (in excess of) dividends received

    517

    (519)

    Net periodic pension benefit cost

    19

    34

    Pension contributions

    (156)

    (1,166)

    Net gain on sales of assets, businesses and investments

    (11)

    (67)

    Restructuring and asset related charges - net

    186

    22

    Other net loss

    159

    874

    Changes in assets and liabilities, net of effects of acquired and divested companies:



    Accounts and notes receivable

    323

    (2,222)

    Inventories

    (254)

    (1,502)

    Accounts payable

    (860)

    1,487

    Other assets and liabilities, net

    (736)

    252

    Cash provided by operating activities - continuing operations

    5,408

    4,512

    Cash used for operating activities - discontinued operations

    (11)

    (78)

    Cash provided by operating activities

    5,397

    4,434

    Investing Activities



    Capital expenditures

    (1,224)

    (1,035)

    Investment in gas field developments

    (134)

    (44)

    Purchases of previously leased assets

    (5)

    (5)

    Proceeds from sales of property and businesses, net of cash divested

    16

    15

    Acquisitions of property and businesses, net of cash acquired

    (54)

    (107)

    Investments in and loans to nonconsolidated affiliates

    (69)

    Distributions and loan repayments from nonconsolidated affiliates

    10

    11

    Proceeds from sales of ownership interests in nonconsolidated affiliates

    11

    Purchases of investments

    (445)

    (1,004)

    Proceeds from sales and maturities of investments

    596

    644

    Other investing activities, net

    (41)

    (10)

    Cash used for investing activities

    (1,339)

    (1,535)

    Financing Activities



    Changes in short-term notes payable

    72

    (44)

    Proceeds from issuance of short-term debt greater than three months

    144

    Payments on short-term debt greater than three months

    (14)

    Proceeds from issuance of long-term debt

    82

    95

    Payments on long-term debt

    (957)

    (2,638)

    Purchases of treasury stock

    (2,200)

    (600)

    Proceeds from issuance of stock

    99

    212

    Transaction financing, debt issuance and other costs

    (8)

    (536)

    Employee taxes paid for share-based payment arrangements

    (34)

    (11)

    Distributions to noncontrolling interests

    (42)

    (35)

    Dividends paid to stockholders

    (1,511)

    (1,561)

    Cash used for financing activities

    (4,513)

    (4,974)

    Effect of exchange rate changes on cash, cash equivalents and restricted cash

    (261)

    (57)

    Summary



    Decrease in cash, cash equivalents and restricted cash

    (716)

    (2,132)

    Cash, cash equivalents and restricted cash at beginning of period

    3,033

    5,108

    Cash, cash equivalents and restricted cash at end of period

    $       2,317

    $       2,976

    Less: Restricted cash and cash equivalents, included in "Other current assets"

    101

    65

    Cash and cash equivalents at end of period

    $       2,216

    $       2,911

     

    Dow Inc. and Subsidiaries

    Net Sales by Segment and Geographic Region

     


    Net Sales by Segment

    Three Months Ended

    Nine Months Ended

    In millions (Unaudited)

    Sep 30,
    2022

    Sep 30,
    2021

    Sep 30,
    2022

    Sep 30,
    2021

    Packaging & Specialty Plastics

    $     7,327

    $     7,736

    $   23,187

    $   20,939

    Industrial Intermediates & Infrastructure

    4,059

    4,481

    12,953

    12,303

    Performance Materials & Coatings

    2,654

    2,526

    8,706

    7,114

    Corporate

    75

    94

    197

    248

    Total

    $   14,115

    $   14,837

    $   45,043

    $   40,604

    U.S. & Canada

    $     5,334

    $     5,476

    $   16,578

    $   14,431

    EMEAI 1

    4,634

    5,229

    15,823

    14,660

    Asia Pacific

    2,571

    2,579

    7,997

    7,423

    Latin America

    1,576

    1,553

    4,645

    4,090

    Total

    $   14,115

    $   14,837

    $   45,043

    $   40,604

     

    Net Sales Variance by
    Segment and
    Geographic Region

    Three Months Ended Sep 30, 2022

    Nine Months Ended Sep 30, 2022


    Local
    Price &
    Product
    Mix

    Currency

    Volume

    Total

    Local
    Price &
    Product
    Mix

    Currency

    Volume

    Total


    Percent change from prior year


    Packaging & Specialty
     Plastics

    (2) %

    (3) %

    — %

    (5) %

    12 %

    (3) %

    2 %

    11 %


    Industrial Intermediates
     & Infrastructure

    5

    (5)

    (9)

    (9)

    15

    (5)

    (5)

    5


    Performance Materials &
     Coatings

    15

    (5)

    (5)

    5

    29

    (4)

    (3)

    22


    Total

    3 %

    (4) %

    (4) %

    (5) %

    16 %

    (4) %

    (1) %

    11 %


    Total, excluding the
     Hydrocarbons &
     Energy business

    4 %

    (4) %

    (8) %

    (8) %

    15 %

    (4) %

    (3) %

    8 %


    U.S. & Canada

    (5) %

    — %

    2 %

    (3) %

    12 %

    — %

    3 %

    15 %


    EMEAI 1

    11

    (10)

    (12)

    (11)

    24

    (9)

    (7)

    8


    Asia Pacific

    2

    (4)

    2

    12

    (3)

    (1)

    8


    Latin America

    1

    1

    11

    3

    14


    Total

    3 %

    (4) %

    (4) %

    (5) %

    16 %

    (4) %

    (1) %

    11 %


     

    Net Sales Variance by Segment and Geographic Region

    Three Months Ended Sep 30, 2022


    Local
    Price &
    Product
    Mix

    Currency

    Volume

    Total


    Percent change from prior quarter


    Packaging & Specialty Plastics

    (7) %

    (1) %

    (3) %

    (11) %


    Industrial Intermediates & Infrastructure

    (5)

    (2)

    (7)


    Performance Materials & Coatings

    (3)

    (2)

    (7)

    (12)


    Total

    (6) %

    (1) %

    (3) %

    (10) %


    Total, excluding the Hydrocarbons & Energy business

    (5) %

    (2) %

    (3) %

    (10) %


    U.S. & Canada

    (4) %

    — %

    (3) %

    (7) %


    EMEAI 1

    (7)

    (3)

    (8)

    (18)


    Asia Pacific

    (7)

    (2)

    5

    (4)


    Latin America

    (4)

    2

    (2)


    Total

    (6) %

    (1) %

    (3) %

    (10) %


  • Europe, Middle East, Africa and India.
  •  

    Dow Inc. and Subsidiaries

    Selected Financial Information and Non-GAAP Measures

     


    Operating EBIT by Segment


    Three Months Ended

    Nine Months Ended

    In millions (Unaudited)


    Sep 30,
    2022

    Sep 30,
    2021

    Sep 30,
    2022

    Sep 30,
    2021

    Packaging & Specialty Plastics


    $       785

    $     1,954

    $     3,455

    $     5,196

    Industrial Intermediates & Infrastructure


    167

    713

    1,254

    1,687

    Performance Materials & Coatings


    302

    284

    1,458

    571

    Corporate


    (59)

    (65)

    (178)

    (186)

    Total


    $     1,195

    $     2,886

    $     5,989

    $     7,268







    Depreciation and Amortization by Segment


    Three Months Ended

    Nine Months Ended

    In millions (Unaudited)


    Sep 30,
    2022

    Sep 30,
    2021

    Sep 30,
    2022

    Sep 30,
    2021

    Packaging & Specialty Plastics


    $       337

    $       354

    $     1,076

    $     1,042

    Industrial Intermediates & Infrastructure


    132

    157

    418

    481

    Performance Materials & Coatings


    195

    207

    592

    642

    Corporate


    4

    7

    18

    22

    Total


    $       668

    $       725

    $     2,104

    $     2,187







    Operating EBITDA by Segment


    Three Months Ended

    Nine Months Ended

    In millions (Unaudited)


    Sep 30,
    2022

    Sep 30,
    2021

    Sep 30,
    2022

    Sep 30,
    2021

    Packaging & Specialty Plastics


    $     1,122

    $     2,308

    $     4,531

    $     6,238

    Industrial Intermediates & Infrastructure


    299

    870

    1,672

    2,168

    Performance Materials & Coatings


    497

    491

    2,050

    1,213

    Corporate


    (55)

    (58)

    (160)

    (164)

    Total


    $     1,863

    $     3,611

    $     8,093

    $     9,455







    Equity in Earnings (Losses) of Nonconsolidated
    Affiliates by Segment


    Three Months Ended

    Nine Months Ended

    In millions (Unaudited)


    Sep 30,
    2022

    Sep 30,
    2021

    Sep 30,
    2022

    Sep 30,
    2021

    Packaging & Specialty Plastics


    $         55

    $       124

    $       303

    $       360

    Industrial Intermediates & Infrastructure


    (114)

    122

    5

    381

    Performance Materials & Coatings


    1

    3

    6

    5

    Corporate


    (3)

    5

    Total


    $        (58)

    $       249

    $       311

    $       751







    Reconciliation of "Net income" to "Operating EBIT"

    Three Months Ended

    Nine Months Ended

    In millions (Unaudited)

    Jun 30,
    2022

    Sep 30,
    2022

    Sep 30,
    2021

    Sep 30,
    2022

    Sep 30,
    2021

    Net income

    $     1,681

    $       760

    $     1,706

    $     3,993

    $     4,644

    + Provision for income taxes

    488

    241

    542

    1,232

    1,383

    Income before income taxes

    $     2,169

    $     1,001

    $     2,248

    $     5,225

    $     6,027

    -  Interest income

    36

    41

    14

    105

    35

    + Interest expense and amortization of debt discount

    165

    155

    178

    487

    561

    -  Significant items

    (77)

    (80)

    (474)

    (382)

    (715)

    Operating EBIT (non-GAAP)

    $     2,375

    $     1,195

    $     2,886

    $     5,989

    $     7,268

     

    Dow Inc. and Subsidiaries

    Selected Financial Information and Non-GAAP Measures

     


    Significant Items Impacting Results for the Three Months Ended Sep 30, 2022

    In millions, except per share amounts (Unaudited)

    Pretax 1

    Net
    Income 2

    EPS 3

    Income Statement Classification

    Reported results

    $   1,001

    $      739

    $     1.02


    Less: Significant items





    Digitalization program costs 4

    (62)

    (47)

    (0.07)

    Cost of sales ($55 million);

    R&D ($2 million); SG&A ($5 million)

    Restructuring, implementation costs and
     asset related charges - net 5

    (11)

    (9)

    (0.01)

    Cost of sales ($8 million);

    R&D ($1 million); SG&A ($2 million)

    Indemnification and other transaction
     related costs 6

    (7)

    (7)

    (0.01)

    Sundry income (expense) - net

    Total significant items

    $      (80)

    $      (63)

    $    (0.09)


    Operating results (non-GAAP)

    $   1,081

    $      802

    $     1.11


     

    Significant Items Impacting Results for the Three Months Ended Sep 30, 2021

    In millions, except per share amounts (Unaudited)

    Pretax 1

    Net
    Income 2

    EPS 3

    Income Statement Classification

    Reported results

    $   2,248

    $   1,683

    $     2.23


    Less: Significant items





    Digitalization program costs 4

    (40)

    (32)

    (0.04)

    Cost of sales ($36 million);

    R&D ($1 million); SG&A ($3 million)

    Restructuring, implementation costs and
     asset related charges - net 5

    (16)

    (13)

    (0.02)

    Cost of sales ($13 million);

    R&D ($2 million); SG&A ($1 million)

    Loss on early extinguishment of debt

    (472)

    (387)

    (0.52)

    Sundry income (expense) - net

    Litigation related charges, awards and
     adjustments

    54

    42

    0.06

    Sundry income (expense) - net

    Total significant items

    $    (474)

    $    (390)

    $   (0.52)


    Operating results (non-GAAP)

    $   2,722

    $   2,073

    $     2.75


  • "Income before income taxes."
  • "Net income available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
  • "Earnings per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
  • Costs associated with implementing the Company's Digital Acceleration program.
  • Restructuring charges, asset related charges and costs associated with implementing the Company's 2020 Restructuring Program.
  • Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.
  •  

    Dow Inc. and Subsidiaries

    Selected Financial Information and Non-GAAP Measures

     


    Significant Items Impacting Results for the Nine Months Ended Sep 30, 2022

    In millions, except per share amounts (Unaudited)

    Pretax 1

    Net
    Income 2

    EPS 3

    Income Statement Classification

    Reported results

    $   5,225

    $   3,969

    $     5.41


    Less: Significant items





    Digitalization program costs 4

    (154)

    (119)

    (0.16)

    Cost of sales ($137 million);

    R&D ($4 million); SG&A ($13 million)

    Restructuring, implementation costs and
     asset related charges - net 5

    (31)

    (25)

    (0.03)

    Cost of sales ($23 million);

    R&D ($5 million); SG&A ($3 million)

    Russia / Ukraine conflict charges 6

    (186)

    (142)

    (0.19)

    Restructuring and asset related charges
     - net

    Loss on early extinguishment of debt

    (8)

    (6)

    (0.01)

    Sundry income (expense) - net

    Indemnification and other transaction
     related costs 7

    (3)

    (3)

    Sundry income (expense) - net

    Income tax related items

    25

    0.03

    Provision for income taxes on
     continuing operations

    Total significant items

    $    (382)

    $    (270)

    $    (0.36)


    Operating results (non-GAAP)

    $   5,607

    $   4,239

    $     5.77


     

    Significant Items Impacting Results for the Nine Months Ended Sep 30, 2021

    In millions, except per share amounts (Unaudited)

    Pretax 1

    Net
    Income 2

    EPS 3

    Income Statement Classification

    Reported results

    $   6,027

    $   4,575

    $     6.06


    Less: Significant items





    Digitalization program costs 4

    (121)

    (94)

    (0.12)

    Cost of sales ($106 million);

    R&D ($2 million); SG&A ($13 million)

    Restructuring, implementation costs and
     asset related charges - net 5

    (69)

    (55)

    (0.07)

    Cost of sales ($39 million);

    R&D ($5 million); SG&A ($3 million);
     Restructuring and asset related
     charges - net ($22 million)

    Loss on early extinguishment of debt

    (574)

    (471)

    (0.63)

    Sundry income (expense) - net

    Litigation related charges, awards and
     adjustments

    54

    42

    0.06

    Sundry income (expense) - net

    Indemnification and other transaction
     related costs 7

    (5)

    (5)

    (0.01)

    Sundry income (expense) - net

    Total significant items

    $    (715)

    $    (583)

    $   (0.77)


    Operating results (non-GAAP)

    $   6,742

    $   5,158

    $     6.83


  • "Income before income taxes"
  • "Net income available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
  • "Earnings per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
  • Costs associated with implementing the Company's Digital Acceleration program.
  • Restructuring charges, asset related charges and costs associated with implementing the Company's 2020 Restructuring Program.
  • Asset related charges including inventory write-downs, bad debt reserves and impairments of other assets related to the conflict between Russia and Ukraine.
  • Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.
  •  

    Dow Inc. and Subsidiaries

    Selected Financial Information and Non-GAAP Measures

     


    Significant Items Impacting Results for the Three Months Ended Jun 30, 2022

    In millions, except per share amounts (Unaudited)

    Pretax 1

    Net
    Income 2

    EPS 3

    Income Statement Classification

    Reported results

    $   2,169

    $   1,661

    $     2.26


    Less: Significant items





    Digitalization program costs 4

    (51)

    (40)

    (0.05)

    Cost of sales ($44 million);

    R&D ($1 million); SG&A ($6 million)

    Restructuring, implementation costs and
     asset related charges - net 5

    (10)

    (8)

    (0.01)

    Cost of sales ($8 million);

    R&D ($2 million)

    Loss on early extinguishment of debt

    (8)

    (6)

    (0.01)

    Sundry income (expense) - net

    Indemnification and other transaction
     related costs 6

    (8)

    (8)

    (0.01)

    Sundry income (expense) - net

    Income tax related items

    25

    0.03

    Provision for income taxes on
     continuing operations

    Total significant items

    $      (77)

    $      (37)

    $   (0.05)


    Operating results (non-GAAP)

    $   2,246

    $   1,698

    $     2.31


  • "Income before income taxes."
  • "Net income available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
  • "Earnings per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
  • Costs associated with implementing the Company's Digital Acceleration program.
  • Restructuring charges, asset related charges and costs associated with implementing the Company's 2020 Restructuring Program.
  • Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.
  •  

    Reconciliation of Free Cash Flow

    Three Months Ended

    Nine Months Ended

    In millions (Unaudited)

    Sep 30,
    2022

    Sep 30,
    2021

    Sep 30,
    2022

    Sep 30,
    2021

    Cash provided by operating activities - continuing operations (GAAP)

    $     1,940

    $     2,719

    $     5,408

    $     4,512

    Capital expenditures

    (452)

    (413)

    (1,224)

    (1,035)

    Free Cash Flow (non-GAAP) 1

    $     1,488

    $     2,306

    $     4,184

    $     3,477

  • Free cash flow in the first six months of 2021 reflects a $1 billion elective pension contribution.
  •  

    Reconciliation of Cash Flow Conversion

    Three Months Ended

    In millions (Unaudited)

    Dec 31,
    2021

    Mar 31,
    2022

    Jun 30,
    2022

    Sep 30,
    2022

    Cash provided by operating activities - continuing operations (GAAP)

    $  2,557

    $  1,612

    $  1,856

    $  1,940

    Operating EBITDA (non-GAAP)

    $  2,920

    $  3,171

    $  3,059

    $  1,863

    Cash Flow Conversion (Operating EBITDA to cash flow from
     operations) (non-GAAP)

    87.6 %

    50.8 %

    60.7 %

    104.1 %

    Cash Flow Conversion - trailing twelve months (non-GAAP)


    72.3 %

     

    For further information, please contact:


    Investors:

    Pankaj Gupta

    pgupta@dow.com

    +1 989-638-5265

    Media:

    Kyle Bandlow

    kbandlow@dow.com

    +1 989-638-2417

    Twitter: https://twitter.com/DowNewsroom 
    Facebook: https://www.facebook.com/dow/ 
    LinkedIn: https://www.linkedin.com/company/dow-chemical 
    Instagram: https://instagram.com/dow_official

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dow-reports-third-quarter-2022-results-301654670.html

    SOURCE The Dow Chemical Company

    Analysen zu Dow Incmehr Analysen

    26.04.24 Dow Overweight JP Morgan Chase & Co.
    25.09.23 Dow Overweight JP Morgan Chase & Co.
    Eintrag hinzufügen
    Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
    Es ist ein Fehler aufgetreten!

    Aktien in diesem Artikel

    Dow Inc 39,87 0,76% Dow Inc